Live
LabiotechViral vector production: How CDMOs influence late-stage development successeLifeAre interphylum spiralian relationships resolvable?FierceBiotechSpyre spies another edge for UC ambitions with midstage win for anti-TL1A antibodyClinical OMICsGenetics of How Steroids Are Metabolized Impacts Adverse EventsClinical OMICsCellular Biological Age Test Can Predict Disease Risk and SurvivalFierceBiotechJapan, South Korea challenge the West’s place in research rankings: reportEndpoints NewsCMS seeks to close Medicare negotiation 'loophole'Endpoints NewsFDA plans to keep Makary priorities on trials, China, deputy saysClinical OMICsTwo Women, One Mission: Closing the Gap Between Cancer Science and SurvivalEndpoints NewsTakeda fortifies orexin potential with more Phase 3 dataBioWorldAppointments and advancements for June 15, 2026BioWorldFinancings for June 15, 2026
FierceBiotech Mar 17, 2026

Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the 'industry is hungriest for'

Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the 'industry is hungriest for'

Original
Body unavailable. Use the original source.